2025. Thiosemicarbazones as promising candidates for the treatment of visceral leishmaniasis: advances and perspectives. Electronic Journal Collection Health. 25, 9 (Sep. 2025), e21502. DOI:https://doi.org/10.25248/reas.e21502.2025.